SynthesisKnee surgery, sports traumatology, arthroscopy : official journal of the ESSKA2023
Lower donor site morbidity with hamstring and quadriceps tendon autograft compared with bone-patellar tendon-bone autograft after anterior cruciate ligament reconstruction: a systematic review and network meta-analysis of randomized controlled trials.
Synthesis in Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
42 citing papers in PubMed, 3 syntheses or guidelines pooled it, 62 citations in OpenAlex.
- Quadriceps, hamstring and patella tendon autografts for primary anterior cruciate ligament reconstruction demonstrate similar clinical outcomes, including graft failure, joint laxity and complications: A systematic review with meta-analysis of randomised controlled trials.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2026Pooled it
- A systematic review of distal medial collateral ligament Stener-like lesion: Good clinical and functional outcomes of surgical treatment.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2026Pooled it
- Quadriceps tendon autograft has similar clinical outcomes when compared to hamstring tendon and bone-patellar tendon-bone autografts for revision ACL reconstruction: a systematic review and meta-analysis.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2023Pooled it
- Quadriceps versus hamstrings autograft in anterior cruciate ligament reconstruction: a randomized control trial.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2025Trial
- Anterior Cruciate Ligament Reconstruction: Clinical Outcomes and Biomechanical Considerations of Graft Selection-A Narrative Review.Medicina (Kaunas, Lithuania) · 2026Review
- Article
- A Single-Bundle Anterior Cruciate Ligament Reconstruction Technique Using Quadrupled Semitendinosus Tendon With Tibial Double Knotless Anchor Fixation And Femoral Suspensory Fixation.Arthroscopy techniques · 2026Article
- Recent advances in immunoregulatory biomaterials for tendon healing: From immune remodeling to functional regeneration.Materials today. Bio · 2026Review
- Pediatric ACL Injuries: A Current Concepts Review.Journal of clinical medicine · 2026Review
- Clinical outcomes of quadriceps, hamstring, and bone-patellar tendon-bone autografts for ACL reconstruction: a meta-analysis of randomized controlled trials.Knee surgery & related research · 2026Review
- Factors Associated with Quadriceps Strength Recovery at 6 and 12 Months After Anterior Cruciate Ligament Reconstruction Using Quadriceps Tendon-Bone, Bone-Patellar Tendon-Bone, and Hamstring Tendon Autografts.Orthopaedic journal of sports medicine · 2026Article
- Higher arterial supply in the distal quadriceps tendon: Results from 7-Tesla quantitative magnetic resonance imaging, histology and high-resolution computed tomography.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2026Article
- The use of additional strands to increase graft diameter in primary ACL reconstruction provides optimal outcomes and does not compromise healing at 12-months follow-up.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2026Article
- Precision anterior cruciate ligament (ACL) reconstruction in high-level athletes.Annals of joint · 2026Review
- Age-related differences in MRI signal intensity of the quadriceps and patellar tendons: Implications for ACL graft selection.Journal of experimental orthopaedics · 2026Article
- Quadriceps tendon autograft for ACL reconstruction: A global survey from the International Quadriceps Tendon Interest Group.Journal of experimental orthopaedics · 2026Article
- Regional Anesthesia Utilizing Liposomal Bupivacaine, With or Without Dexamethasone, Provides Excellent Pain Control and Minimizes Opioid Consumption Following Anterior Cruciate Ligament Reconstruction.Orthopaedic journal of sports medicine · 2026Article
- Rehabilitation guidelines after autograft anterior cruciate ligament reconstruction need more graft-specific exercise recommendations-A scoping review.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2026Article
- CLINICAL OUTCOMES OF ACL RECONSTRUCTION WITH THREE DIFFERENT AUTOGRAFTS.Acta ortopedica brasileira · 2026Article
- Sensory Deficit Following Anterior Cruciate Ligament Reconstruction with Bone-Patellar Tendon-Bone Autograft: Platelet-Rich Fibrin (PRF) Could Provide a Solution.Medicina (Kaunas, Lithuania) · 2025Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo perform a meta-analysis of RCTs evaluating donor site morbidity after bone-patellar tendon-bone (BTB), hamstring tendon (HT) and quadriceps tendon (QT) autograft harvest for anterior cruciate ligament reconstruction (ACLR).
methodsPubMed, OVID/Medline and Cochrane databases were queried in July 2022. All level one articles reporting the frequency of specific donor-site morbidity were included. Frequentist model network meta-analyses with P-scores were conducted to compare the prevalence of donor-site morbidity, complications, all-cause reoperations and revision ACLR among the three treatment groups.
resultsTwenty-one RCTs comprising the outcomes of 1726 patients were included. The overall pooled rate of donor-site morbidity (defined as anterior knee pain, difficulty/impossibility kneeling, or combination) was 47.3% (range, 3.8-86.7%). A 69% (95% confidence interval [95% CI]: 0.18-0.56) and 88% (95% CI: 0.04-0.33) lower odds of incurring donor-site morbidity was observed with HT and QT autografts, respectively (p < 0.0001, both), when compared to BTB autograft. QT autograft was associated with a non-statistically significant reduction in donor-site morbidity compared with HT autograft (OR: 0.37, 95% CI: 0.14-1.03, n.s.). Treatment rankings (ordered from best-to-worst autograft choice with respect to donor-site morbidity) were as follows: (1) QT (P-score = 0.99), (2) HT (P-score = 0.51) and (3) BTB (P-score = 0.00). No statistically significant associations were observed between autograft and complications (n.s.), reoperations (n.s.) or revision ACLR (n.s.).
conclusionACLR using HT and QT autograft tissue was associated with a significant reduction in donor-site morbidity compared to BTB autograft. Autograft selection was not associated with complications, all-cause reoperations, or revision ACLR. Based on the current data, there is sufficient evidence to recommend that autograft selection should be personalized through considering differential rates of donor-site morbidity in the context of patient expectations and activity level without concern for a clinically important change in the rate of adverse events. LEVEL OF EVIDENCE: Level I.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.